Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Safety Of Hyperbaric Oxygen Therapy In Patients Aged 75 And Older: A Multicenter Retrospective Study
View through CrossRef
Cracchiolo AN, Palma DM, Saporito EFG, Palazzolo C, Mannino SM, Genco F, Vitale F, Profera L, Raineri SM, Accurso G. Safety Of Hyperbaric Oxygen Therapy In Patients Aged 75 And Older: A Multicenter Retrospective Study. Undersea Hyperb Med. 2025 Fourth Quarter; 52(4):495-506.
Background: The increasing life expectancy presents new challenges in managing elderly patients requiring hyperbaric oxygen (HBO2) therapy. This retrospective study evaluates the safety and adherence to HBO2 guidelines in patients aged 75 years and older, focusing on side effects and adverse events.
Methods: Data from 69 elderly patients treated between 2019 and 2023 at two Sicilian hyperbaric centres were analyzed. Demographics, indications for HBO2, comorbidities, treatment protocols, and side effects were collected. Pre-treatment evaluations included ENT checkups, ECG, chest X-rays, and laboratory tests. Patients underwent HBO2 sessions at 2.4–2.8 ATA, with clinical monitoring pre-and post-treatment.
Results: 1,799 HBO2 sessions were performed in 69 patients (mean age 78 years; 59.4% male). The most common indications were progressive necrotizing infections (33.3%), sudden sensorineural hearing loss (17.3%), and chronic radiation-induced tissue injuries (14.5%). Side effects occurred in 14 patients (20.3%), primarily middle ear barotrauma (8.7%), sinus barotrauma (4.3%), confinement anxiety (4.3%), hypoglycemia (1.4%), and chest pain (1.4%). Most side effects were resolved with prompt care, and
no life-threatening events were recorded. Adherence to guidelines and meticulous pre-treatment evaluations minimized risks.
Conclusions: HBO2 is a safe therapeutic option for elderly patients when strict pre-treatment evaluations and monitoring protocols are implemented. Despite this population's increased vulnerability, the incidence of side effects was comparable to that in younger cohorts. Future research is warranted to optimize treatment protocols and explore outcomes in larger elderly populations.
Keywords: adverse events; elderly patients; guidelines; hyperbaric oxygen therapy; safety,
Undersea and Hyperbaric Medical Society (UHMS)
Title: Safety Of Hyperbaric Oxygen Therapy In Patients Aged 75 And Older: A Multicenter Retrospective Study
Description:
Cracchiolo AN, Palma DM, Saporito EFG, Palazzolo C, Mannino SM, Genco F, Vitale F, Profera L, Raineri SM, Accurso G.
Safety Of Hyperbaric Oxygen Therapy In Patients Aged 75 And Older: A Multicenter Retrospective Study.
Undersea Hyperb Med.
2025 Fourth Quarter; 52(4):495-506.
Background: The increasing life expectancy presents new challenges in managing elderly patients requiring hyperbaric oxygen (HBO2) therapy.
This retrospective study evaluates the safety and adherence to HBO2 guidelines in patients aged 75 years and older, focusing on side effects and adverse events.
Methods: Data from 69 elderly patients treated between 2019 and 2023 at two Sicilian hyperbaric centres were analyzed.
Demographics, indications for HBO2, comorbidities, treatment protocols, and side effects were collected.
Pre-treatment evaluations included ENT checkups, ECG, chest X-rays, and laboratory tests.
Patients underwent HBO2 sessions at 2.
4–2.
8 ATA, with clinical monitoring pre-and post-treatment.
Results: 1,799 HBO2 sessions were performed in 69 patients (mean age 78 years; 59.
4% male).
The most common indications were progressive necrotizing infections (33.
3%), sudden sensorineural hearing loss (17.
3%), and chronic radiation-induced tissue injuries (14.
5%).
Side effects occurred in 14 patients (20.
3%), primarily middle ear barotrauma (8.
7%), sinus barotrauma (4.
3%), confinement anxiety (4.
3%), hypoglycemia (1.
4%), and chest pain (1.
4%).
Most side effects were resolved with prompt care, and
no life-threatening events were recorded.
Adherence to guidelines and meticulous pre-treatment evaluations minimized risks.
Conclusions: HBO2 is a safe therapeutic option for elderly patients when strict pre-treatment evaluations and monitoring protocols are implemented.
Despite this population's increased vulnerability, the incidence of side effects was comparable to that in younger cohorts.
Future research is warranted to optimize treatment protocols and explore outcomes in larger elderly populations.
Keywords: adverse events; elderly patients; guidelines; hyperbaric oxygen therapy; safety,.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Leder Macek AJ, Wang RS, Cottrell J, Kay-Rivest E, McMenomey SO, Roland Jr. T, Ross FL. Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens. Unders...
Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Development, nor Reduce Disease Specific or Overall Survival
Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Development, nor Reduce Disease Specific or Overall Survival
ABSTRACT
Hsieh CH, Wen YW, Liao CT, Lee SR. Hyperbaric Oxygen Treatment after Surgery and Radiation for Oral Cancers Does not Increase the Likelihood of a Second Primary Developmen...
High Concentration Oxygen and Hypercapnia in Respiratory Disease
High Concentration Oxygen and Hypercapnia in Respiratory Disease
<p>Oxygen-induced elevations in arterial carbon dioxide tension have been demonstrated in patients with chronic obstructive pulmonary disease (COPD), asthma, pneumonia, obesi...
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Objective: Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 pa...
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Objective: Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 pa...
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Objective: Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 pa...
Safety and efficacy of continuous glucose monitoring devices in individuals with diabetes undergoing hyperbaric oxygen therapy: a scoping review
Safety and efficacy of continuous glucose monitoring devices in individuals with diabetes undergoing hyperbaric oxygen therapy: a scoping review
Introduction: Continuous glucose monitoring devices (CGMs) have emerged as an effective approach to optimise glycaemic control for individuals living with diabetes mellitus. Despit...